Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2005
11/16/2005EP1220661B1 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
11/16/2005EP1216053B1 Influenza vaccine
11/16/2005EP1216036B1 Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines
11/16/2005EP1146857B1 Materials and methods for making improved micelle compositions
11/16/2005EP1109837B1 Method for producing ultra-pure alginates
11/16/2005EP1085914B1 Plaster containing an active agent
11/16/2005EP1011635B1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
11/16/2005EP1003522B1 Use of estrogen for preventing or controlling cataract
11/16/2005EP0923370B1 Acetyl choline esterase inhibitors for treating and diagnosing sleep disordered breathing
11/16/2005EP0904099B1 Pharmaceutical formulation containing human growth hormone, histidine and a non-ionic detergent
11/16/2005EP0766538B1 Subcutaneous implant
11/16/2005CN2740191Y Externally-applied skin paste
11/16/2005CN2740190Y Externally-applied paste for treating respiratory tract infection
11/16/2005CN1697840A Viscoelastic material
11/16/2005CN1697663A Antitumor agent and process for producing the same
11/16/2005CN1697662A Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
11/16/2005CN1697656A Phentanyl-containing adhesive patch for application to oral-cavity mucosa
11/16/2005CN1697653A Particulate product comprising pantethine
11/16/2005CN1697652A Adhesive patch containing tulobuterol
11/16/2005CN1697649A Dosage form and method for producing the same
11/16/2005CN1697648A Azithromycin dosage forms with reduced side effects
11/16/2005CN1697647A Liquor and method for restraining ache, inflammation and cartilage degradation
11/16/2005CN1695735A Application of kininogenase of human urine in preparing medication for treating pyemia
11/16/2005CN1695600A Method for preparing components, capsules and capsule wall material of combination of natural polysaccharide macromolecules
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227316C Pressure sensitive conductive adhesive having hot-melt properties and biomedical electrodes using same
11/16/2005CN1227024C Chinese traditional medicine for preventing and treating cardiac and cerebral vascular diseases and its preparation
11/16/2005CN1227023C Drug for treating coronary heart disease, angina and preparation method
11/16/2005CN1227021C Capsule with high cellulose for expelling of toxin and nourishing skin as well as its manufacturing methods
11/16/2005CN1227012C Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
11/16/2005CN1227011C Method of treating adenosine depletion
11/16/2005CN1227009C Pharmaceutical composition containing porton pump inhibitors
11/16/2005CN1227007C Cannabinoid drugs
11/16/2005CN1227006C Pharmaceuticals comprising N,N'-BIS(2-Hydroxybenzy) ethylenediamine-N, N'-diacetic acid for iron chelating therapy
11/16/2005CN1227005C Nimesulide containing topical pharmaceutical compositions
11/16/2005CN1227004C Partial fatty acid oxidation inhibitors in treatment of congestive heart failure
11/16/2005CN1227003C Dosage form comprising liquid formulation
11/16/2005CN1227002C Active content contained floating form having polyacetic vinylester and polyvinyl pyrrolidone, its preparation and use
11/16/2005CN1227001C Extended release formulation of etodolac
11/16/2005CN1227000C Using W/O emulsions as thickeners in cosmetic and pharmaceutical formulations
11/16/2005CN1226999C Solubilized pharmaceutical composition for parenteral administration
11/16/2005CN1226998C Controllable released type milk duct suppository
11/16/2005CN1226994C Method of cosmetology
11/16/2005CN1226982C Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system
11/16/2005CN1226973C Vacuum assisted closure system with provision for introduction of agent
11/15/2005US6965049 Zwitterionic lipid compound and uses thereof
11/15/2005US6965005 Mold inhibitor integrated within a matrix and method of making same
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964959 Use of a methylol-containing compound to treat tumors
11/15/2005US6964953 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
11/15/2005US6964946 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
11/15/2005US6964783 Non-solid composition for local application
11/15/2005US6964782 Stable hydrogen peroxide compositions, products and methods of use
11/15/2005US6964781 For delivering drug directly to the interior portions of the body of a mammalian organism, such as to the eye
11/15/2005US6964780 Phosphodiesterase inhibitor; therapy for sexual disorders; sildenafil in polyoxyethylene glycol enteric coating
11/15/2005US6964778 Temperature controlled content release from liposomes
11/15/2005US6964777 An antianxiety agent such as buspirone; a dermal penetration enhancer of given formula such as octyl salicylate; and a volatile liquid such as ethanol
11/15/2005US6964772 Chitosan-xanthan based polyionic hydrogels for stabilization and controlled release of vitamins
11/15/2005US6964771 Storage stability; foamed glass containign active material ; boiling, foaming
11/15/2005US6964761 Administering and depositing interferon in the lungs; for patients are unresponsive to treatment with corticosteroid, cyclophosphamide, and azathioprine; therapeutic dosage pluse immunosuppressant or antiinflammatory agent; drug delivery
11/15/2005US6964759 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
11/15/2005CA2352190C Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
11/15/2005CA2343148C Quick release pharmaceutical compositions of drug substances
11/15/2005CA2294067C Device for delivery of dermatological ingredients
11/15/2005CA2279204C Use of microparticles with adsorbed antigen to stimulate immune responses
11/15/2005CA2235617C Therapeutic preparation for the transdermal administration of active substances
11/15/2005CA2226147C Layered tablet for the controlled release of active substances
11/15/2005CA2172401C Transdermal therapeutic system with acetylsalicylic acid as active substance
11/15/2005CA2153787C Solution containing igf-1
11/15/2005CA2092346C Protein stabilised oil-in-water emulsions
11/10/2005WO2005106121A1 Paper tissue with high lotion transferability
11/10/2005WO2005105886A1 Low molecular weight polylactic acid polymers
11/10/2005WO2005105317A2 Electrostatic application of powder material to solid dosage forms
11/10/2005WO2005105278A2 Antisolvent emulsion solidification process
11/10/2005WO2005105181A1 Medical device for generating transient bubbles
11/10/2005WO2005105167A1 Injectable crosslinked and uncrosslinked alginates and the use thereof in medicine and in cosmetic surgery
11/10/2005WO2005105154A1 Polymer conjugate releasable under mild thiolytic conditions
11/10/2005WO2005105150A1 Adhesive material
11/10/2005WO2005105136A1 Nanogene therapy for cell proliferation disorders
11/10/2005WO2005105120A2 Pharmaceutical combination, active on central nervous system (cns) and set of pharmaceuticals; method of treatment of cns-disorders; means facilitating penetration of the hematoencephalic barrier; pharmaceutical means for endonasal administration
11/10/2005WO2005105119A1 5-aminosalicylic acid of slow-released type in magnetic intercalated structure and the preparation method thereof
11/10/2005WO2005105109A1 Oral modified-release lozenges and their preparation method
11/10/2005WO2005105104A1 Transdermal steroid formulation
11/10/2005WO2005105102A1 Improved nsaid composition
11/10/2005WO2005105101A1 Use of meloxicam formulations in veterinary medicine
11/10/2005WO2005105090A1 Compositions for progeny gender control
11/10/2005WO2005105072A2 Antifungal drug delivery
11/10/2005WO2005105070A2 Therapeutic antimicrobial compositions and methods
11/10/2005WO2005105069A1 Statins for the treatment of ocular hypertension and glaucoma
11/10/2005WO2005105067A2 Aqueous solutions comprising prednisolone and a cyclodextrin derivative
11/10/2005WO2005105061A2 Transdermal patch
11/10/2005WO2005105060A1 Plaster
11/10/2005WO2005105059A1 Permeation enhancer comprising genus curcuma or germacrone for transdermal and topical administration of active agents
11/10/2005WO2005105058A1 Sustained-releasing injectable formulation for the treatment or prevention of bone-related diseases comprising bisphorenate-containing polymeric microparticles
11/10/2005WO2005105057A1 Sustained release formulations
11/10/2005WO2005105056A1 Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer
11/10/2005WO2005105055A1 Formulation comprising histone deacetylase inhibitors
11/10/2005WO2005105054A1 Dosage form having polymorphic stability
11/10/2005WO2005105053A2 Active drug delivery in the gastrointestinal tract
11/10/2005WO2005105052A1 Novel oral formulations of ospemifene
1 ... 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 ... 2991